Market Research Report
Dyslipidemia Disease Analysis and Market and Forecast Analysis 2024
|Published by||Datamonitor Healthcare||Product code||858221|
|Published||Content info||546 Pages
Delivery time: 1-2 business days
|Dyslipidemia Disease Analysis and Market and Forecast Analysis 2024|
|Published: June 7, 2018||Content info: 546 Pages||
Dyslipidemia refers to any increase or decrease in lipid levels from defined normal parameters, with physicians particularly focusing on the treatment of elevated LDL-C due to the well-established link between excessively elevated LDL-C and atherosclerosis. As such, LDL-C is a major modifiable risk factor for cardiovascular disease, one of the world's leading causes of morbidity and mortality. Other lipid level deviations in dyslipidemia include low levels of HDL-C, elevated total cholesterol, and elevated triglycerides.